Enovis Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ENOV research report →
Companywww.enovis.com
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger.
- CEO
- Damien McDonald
- IPO
- 2008
- Employees
- 7,367
- HQ
- Wilmington, DE, US
Price Chart
Valuation
- Market Cap
- $1.51B
- P/E
- -1.31
- P/S
- 0.66
- P/B
- 1.01
- EV/EBITDA
- -14.96
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 56.81%
- Op Margin
- 2.70%
- Net Margin
- -49.91%
- ROE
- -60.13%
- ROIC
- 1.87%
Growth & Income
- Revenue
- $2.25B · 6.66%
- Net Income
- $-1,184,440,000 · -43.48%
- EPS
- $-20.86 · -39.72%
- Op Income
- $-18,869,000
- FCF YoY
- 129.63%
Performance & Tape
- 52W High
- $36.82
- 52W Low
- $21.00
- 50D MA
- $23.97
- 200D MA
- $27.06
- Beta
- 1.52
- Avg Volume
- 1.03M
Get TickerSpark's AI analysis on ENOV
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 12, 26 | McDonald Damien | other | 12,634 |
| May 12, 26 | BERRY PHILLIP BENJAMIN (BEN) | other | 7,774 |
| Apr 3, 26 | Singleton Laura Lee | other | 0 |
| Apr 3, 26 | Singleton Laura Lee | other | 1,091 |
| Mar 31, 26 | Ortiz Christine | other | 770 |
| Mar 13, 26 | Engert Oliver | buy | 1,000 |
| Mar 10, 26 | Engert Oliver | buy | 1,000 |
| Mar 9, 26 | KLECKNER JOHN | other | 14,925 |
| Mar 7, 26 | KLECKNER JOHN | other | 586 |
| Mar 9, 26 | ROSS TERRY D | other | 36,247 |
Our ENOV Coverage
We haven't published any research on ENOV yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ENOV Report →